An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.
about
Cardiac regeneration and diabetesAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsUse of Adult Stem Cells for Cartilage Tissue Engineering: Current Status and Future DevelopmentsInduction of pluripotency by defined factorsNon-viral methods for generating integration-free, induced pluripotent stem cellsMechanisms and models of endoplasmic reticulum stress in chondrodysplasiaOptimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cellsIn vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations.Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke RatsSelf-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease PhenotypesTechniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell DerivationConcise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem CellsStem Cells: Potential Therapy for Neonatal Injury?Retinal pigment epithelium transplantation: concepts, challenges, and future prospectsChoices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming StrategiesSomatic cell nuclear transfer: origins, the present position and future opportunitiesSignaling Pathways and Gene Regulatory Networks in Cardiomyocyte DifferentiationA mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxiaVascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculatureDifferences and similarities between human and chimpanzee neural progenitors during cerebral cortex developmentHuman finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.Human stem cells for craniomaxillofacial reconstruction.Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in MicePractical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells.Recent technological updates and clinical applications of induced pluripotent stem cellsCell signalling pathways underlying induced pluripotent stem cell reprogrammingAdvanced feeder-free generation of induced pluripotent stem cells directly from blood cells.Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells.Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells.Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damageEfficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factorsTreatment with retinoic acid and lens epithelial cell-conditioned medium in vitro directed the differentiation of pluripotent stem cells towards corneal endothelial cell-like cellsAdult somatic cells to the rescue: nuclear reprogramming and the dispensability of gonadal germ cells.Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.A comparison of non-integrating reprogramming methods.A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.KLF4 N-terminal variance modulates induced reprogramming to pluripotency
P2860
Q54603888-86C791F0-503B-45D3-A1CA-CA30ED12EF2EQ54603890-51B4DF54-8FFC-4F7D-94EF-15134295F635Q54604230-47624968-26D3-409F-9CD1-CBEAF1BD69F7Q54604318-E34E6515-B69B-4965-9420-FCA8851739AAQ54604387-7D853569-A220-468D-8182-8E2736F58567Q54604388-C623AF63-359B-4B9E-8266-46685B479422Q54604497-E99AE902-1733-4A3A-B565-88C1911D87F4Q54604498-58444712-2F44-43C5-A959-9BE31254DA1E
P1343
Q21195758-B151688E-4B34-44BD-A017-4F8DA89E6A2EQ26775122-8063B1DE-E46F-4B18-94DD-92C561BA7E78Q26798211-7E5F4AC6-AF76-4911-87A6-8216E9066E37Q26830425-03C00B25-CD0B-4B1F-982B-835D33524F70Q26861483-91A32BD5-2D37-4074-BC42-FD088B2911E9Q26995280-1EA5B700-8747-4261-BA28-05E0B50C7C32Q27015774-39299CD7-602A-49F9-BDAE-86A8F4D9C11FQ27300744-33A104AF-E613-4CFE-BA14-FEAD45F6E53BQ27319949-EBDA3535-5310-4240-9528-CF2BB6B724D2Q27324311-3471E6FD-6C94-4829-B582-53B23A7AAB1EQ28066087-966930B8-E285-4A72-A59B-79C411ED8A35Q28081651-030E773C-F58E-4B92-99EF-AD5112951A73Q28082268-97212737-3ECD-4F17-91B3-B6BF05A3F34FQ28083235-DD4C949E-851B-44AD-B1F0-270C6750B60AQ28085565-B646AE99-2E49-426A-86EE-BBEEC7F15E0AQ28085602-E0569C41-F9E6-47D9-9ED4-C38D5CAF58B5Q28087290-F5625D7D-5F4F-4779-AC77-976CEDF7EEDCQ28116910-128C0B42-3BA4-4675-A838-B3221EE4325AQ28655924-4F7C5175-9383-4C1F-A782-5A95AD5CE30EQ28973606-548648B5-321D-4058-91A6-58E6FD651CD5Q30577389-BFBB77E4-6F72-43BD-AB1E-75D8DA129878Q30838313-0B3F9ECF-5CCF-4AF3-A79F-511AEC61364AQ33788845-026572FF-9623-404D-85EB-50A53A1ADC5BQ34039059-C1675F53-2821-4C66-BD51-AF283B991D59Q34044521-03DA36B6-242B-49AD-964E-A73C170993F1Q34045087-A2071038-890F-4C5D-BAFC-30865F09DB4CQ34184553-BACB3686-8715-4D7B-AEAC-89383AF901C0Q34259132-DE4128C9-A890-449F-86C0-FB3D09C9B5F8Q34601924-58F37274-B4CF-4F1E-BB59-1BC2C8F26B42Q34661781-722E174E-FB2F-438C-9F14-7F54F19ADD74Q34699730-19BC18C3-0B4D-460E-9546-B87B179AD6C0Q34699757-A9AF0278-5260-428F-B386-FCD5B4BF3C77Q34738075-8DD1953F-6DEE-4492-BE72-AB59BB7607B3Q34795607-4E556D87-D0B9-4353-8FED-3CDB7D246D62Q34850388-DB3B4961-0728-4DF9-AF98-2085FFB80302Q35002134-D75EEBF3-2A94-4C8A-843B-21BE694D6D52Q35074117-CCEF2E1A-89E7-43D7-94D3-5390ED7E10FCQ35087542-0237A759-8BD6-460B-AFC1-77A142E389D7Q35200170-B25DC273-AB1E-4B5B-8B72-26C1B3AD13D2Q35453993-1C25B914-5072-483B-A131-81FB4C6D1C05
P2860
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An efficient nonviral method t ...... od and peripheral blood cells.
@ast
An efficient nonviral method t ...... od and peripheral blood cells.
@en
An efficient nonviral method t ...... od and peripheral blood cells.
@nl
type
label
An efficient nonviral method t ...... od and peripheral blood cells.
@ast
An efficient nonviral method t ...... od and peripheral blood cells.
@en
An efficient nonviral method t ...... od and peripheral blood cells.
@nl
prefLabel
An efficient nonviral method t ...... od and peripheral blood cells.
@ast
An efficient nonviral method t ...... od and peripheral blood cells.
@en
An efficient nonviral method t ...... od and peripheral blood cells.
@nl
P2093
P2860
P4510
P356
P1433
P1476
An efficient nonviral method t ...... od and peripheral blood cells.
@en
P2093
Akira Watanabe
Keisuke Okita
Naoki Amano
Naoki Goshima
Tatsuya Yamakawa
Yasuko Matsumura
Yoshiko Sato
P2860
P304
P356
10.1002/STEM.1293
P577
2013-03-01T00:00:00Z